半年480亿美元!创纪录授权交易背后,中国如何重塑全球制药版图?

华尔街见闻
22 Jul

在全球医药行业承压、地缘政治升温的背景下,一场悄无声息的“制药权力转移”正在上演:仅今年上半年,中国药企出海交易总额已达480亿美元,占全球药物授权交易的32%,好于此前任何一年。 中国不再是原料药的代工厂,而正成为全球创新药的“发源地”,正如启明创投创始管理合伙人此前表示,中国创新药正在迎来“DeepSeek时刻”。 而这背后既有技术能力的跃升,也有产业政策、资本推动、全球医药格局变迁的合力结果...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10